• <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
    来宝网Logo

    热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

    现在位置首页>技术资料首页>行业动态>展会及会议>BIOTEC-CHINA 2018之赞助商推荐-DMG Deutsche Malaria GmbH

    BIOTEC-CHINA 2018之赞助商推荐-DMG Deutsche Malaria GmbH

    上海广贸会展服务有限公司2018年9月17日 2:46 点击:249


    DMG Deutsche Malaria GmbH

    Deutsche Malaria is based in Hamburg, the German partner city of Shanghai. It is a privately owned company financed by corporate and individual investors.

    The company has commanded outstanding scientists, researchers and top medical institutions in Germany, SE Asia and Africa to develop a new and safe therapy against malaria. It is called fosmidomycin and is administered in combination with other antimalarials as a highly effective, well tolerated and safe treatment. It may also have a role in the initial treatment of severe malaria.   

    The artemisinin therapies first developed by Tu Youyou, Nobel Laureate of 2015, are becoming less effective due to resistant malaria parasites. This is a matter of considerable concern. As fosmidomycin is not cross-resistant with the artemisinin derivatives, it could play an important role in areas where artemisinin is losing its effectiveness. 

    Hence projects being pioneered by Deutsche Malaria maybe very well positioned for scientific and commercial cooperation with Chinese institutions and companies to bring new, powerful and safe solutions to fight malaria. Deutsche Malaria is very interested to join with partners to bring these projects to fruition. A number of these projects are aimed at fighting malaria in Africa and could be quickly implemented. 

    China has a high interest in the development of Africa as was shown on the Forum of China-Africa Cooperation at the beginning of September in Beijing, where President Xi Jinping announced US $ 60 billion in support for African countries. 

    Health is one of the most important issues to improve the quality of life. More than 200 million people fall ill with malaria each year. About 80% of the nearly 500,000 deaths each year are African children. This is very concerning and unacceptable but it can be changed. At the same time, new and effective therapies for travellers to Africa on business or as tourists are much needed. 

    Deutsche Malaria has solutions and is looking for dialogue and partnerships at the BIOTEC-CHINA 2018 conference.

    Deutsche Malaria CEO Dr David BA Hutchinson has been invited as the keynote speaker in the conference and the speech title is  Meeting the challenge of artemisinin resistance with fosmidomycin combination therapy. A novel approach with safety in children at the forefront   

     



    CONTACT DETAILS
    DMG Deutsche Malaria GmbH
    Neuer Wall 72
    20354 Hamburg
    Germany
    Voice  +49-40-81 80 28
    Cell    +49-40-172 916 13 66
     
    UK Office
    Betsoms Farmhouse, Pilgrims Way
    Westerham, Kent TN16 2DR
    England
    Dr David BA Hutchinson
    Managing Director
    [email protected]
    Voice +44 - 1959 - 56 34 87
    Fax +44 - 1959 - 56 29 31

     

    DMG Deutsche Malaria GmbH

    Deutsche Malaria总部位于德国上海友?#36152;?#24066;汉堡市。它是一家由企业和个人投?#25910;?#36164;助的私人公司。

    该公司已聚集来自德国,东南亚和非洲的杰出科学家,研究人员和顶级医疗机构开发出一?#20013;?#30340;安全的疟疾?#21697;ā?#23427;被称为fosmidomycin,与其他抗疟药联合使用,是一种高效,耐药性良好且安全的治?#21697;?#27861;。它?#37096;?#20197;在?#29616;?#30111;疾的初始治疗中发挥作用。

    最初由2015年诺贝尔?#34987;?#24471;者屠呦呦开发的青蒿素?#21697;?#30001;于疟?#24067;?#29983;虫的耐药性而变得不那么?#34892;А?#36825;是一个值得关注的问题。由于fosmidomycin与青蒿素衍生物不具有交叉耐药性,因此它可能在青蒿素失去其?#34892;?#24615;的地区发挥重要作用。

    因此,由Deutsche Malaria开创的项目可能非常适合与中国机?#36141;?#20844;司进行科学和商业合作,为抗击疟疾带来新的,?#30475;?#30340;和安全的解决方案。Deutsche Malaria非常?#34892;?#36259;与合作伙伴一起实现这些项目。其中一些项目旨在打击非洲的疟疾,并可迅速实施。

    中国对非洲的发展有着浓厚的兴趣,正如9月初中非合作论坛在?#26412;?#25152;展?#38236;?#37027;样,习近平主席宣布向非洲国家提供600亿美元的支持。

    健康是改善生活质量的最重要问题之一。每年有2亿多人患有疟疾。每年近500,000死亡人数中约有80%是非洲儿童。这是非常令人担忧和不?#23665;?#21463;的,但这种现象可以改变。与此同时,非常需要为非洲商务旅行者或游客提供新的?#34892;Я品ā?/span>

    Deutsche Malaria有良好的解决方案,并正在BIOTEC-CHINA 2018年会上寻求对话和合作。

    Deutsche Malaria CEO Dr David BA Hutchinson 受邀出席BIOTEC-CHINA 2018年年会并做大会主旨报告,报告题目:fosmidomycin联合?#21697;?#24212;对青蒿素抗药性的挑?#20581;?一种治疗疟疾的并对儿童安全的全新?#21697;ā?/span>

     

    联系我们:
    DMG Deutsche Malaria GmbH
    Neuer Wall 72
    20354 汉堡 德国
    Voice  +49-40-81 80 28
    Cell    +49-40-172 916 13 66
     
    UK Office
    Betsoms Farmhouse, Pilgrims Way
    Westerham, Kent TN16 2DR
    英格兰
    Dr David BA Hutchinson
    总经理
    [email protected]
    Voice +44 - 1959 - 56 34 87
    Fax +44 - 1959 - 56 29 31

     

    BIOTEC-CHINA 作为国内生物技术领域专业的国际会议与展览会,将在全球范围内邀请参会代表、参展企业与专业观众,致力于为生物技术领域搭建贸易与交流的国?#24066;?#24179;台,为生物技术领域产学研用不同单位在不同发展阶段寻找最合?#23454;?#21512;作伙伴。 

    BIOTEC-CHINA 2018 热诚欢迎您的参与!

     

    联系我们:

    2018中国国际生物技术大会暨展览会

    上海广贸会展服务有限公司
    BIOTEC 国际生物技术专家委员会

    电话:86-17755636132

    邮箱:contact@bonetec-china.com  

    官网:http://www.biotec-china.com/ 

     


    (来源: 上海广贸会展服务有限公司 )


    全年征稿 / 资讯合作

    联系邮箱:[email protected]

    版权与免责声明

    • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://www.67994619.com,违反者本网将追究相关法律责任。
    • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
    • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联?#25285;?#21542;则视为?#29260;?#30456;关权利。


    云南11选5技巧
  • <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
  • <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
    nba2k19手机版球探怎么签约 十一运夺金时间 网球规则视频教程 最新河南22选5走势图百度 买江西时时彩的技巧 广西快三走势图 六肖中特准资料大全 欢乐升级下载安卓版本 今期最佳特马资料 网上买彩票 手机微信赌牛牛老是输 kk体育是合法的吗 快赢彩票网是真的假的 扑克山庄赢话费 体彩宁夏11选